Percy Van Crocker, Jr.

From 2013 to 2020, Crocker led Healthagen, a division of Aetna/CVS that enables highly impactful health research in payer environments. He transformed Healthagen from an idea into a fast-growing, profitable and well-known analytics business serving the pharmaceutical sector and others.

Prior to Healthagen, Crocker led finance and business development for AuraSense, a biotechnology company founded by world-renowned nanotechnology authority, Dr. Chad Mirkin, and funded in part by AbbVie Biotech Ventures and Bill Gates. The company developed a broad array of nanoparticle-based genetic therapies and diagnostic platforms with applications in cancer and autoimmune conditions. AuraSense has thus far spawned the public company, Exicure. Prior to AuraSense, he was a management consultant with Booz & Company, focusing on strategic transactions and initiatives for payer/provider clients. He began his career with Oracle Corporation.

Crocker holds an MBA (Honors) from Kellogg School of Management at Northwestern University in Illinois and a BS from the University of Virginia.